Previous 10 |
Sunesis Pharmaceuticals (NASDAQ: SNSS ): Q3 GAAP EPS of -$0.18 beats by $0.01. More news on: Sunesis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the quarter ended September 30, 2018. Loss from operations for the three and nin...
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced two poster presentations and an oral presentation at the 60 th American Society of Hematology (ASH) Annual Meeting being held December 1-4, 2018 in San Diego, Califor...
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 5 th , 2018 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the third quarter ...
Introduction: Since it was first approved to treat mantle cell lymphoma in 2013, ibrutinib (Imbruvica) has rapidly become a hematology hegemon. In 2017, AbbVie ( ABBV ) reported over $2.5 billion in net revenues for ibrutinib, a 40% increase over 2016, and forecasts $5 bn in annual sales ...
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate Development of Sunesis, will present at the Wells Fargo Securities 2018 Hea...
Sunesis Pharmaceuticals, Inc. (SNSS) Q2 2018 Earnings Conference Call August 7, 2018 4:30 PM ET Executives Willie Quinn – Chief Financial Officer and Senior Vice President-Corporate Development Dayton Misfeldt – Interim Chief Executive Officer Judy Fox – Chie...
Sunesis Pharmaceuticals (NASDAQ: SNSS ): Q2 EPS of -$0.20 beats by $0.04 . More news on: Sunesis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Viracta Therapeutics Inc Com Company Name:
SNSS Stock Symbol:
NASDAQ Market:
Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement Shares of Viracta to commence trading on the Nasdaq Global Select Market on February 25, 2021 under ticker symbol 'VIRX' Cash and cash equivalents of over $120 million as...
There’s Blood In The Streets, But Opportunity Could Be Presenting Itself With Penny Stocks What’s your strategy for finding the best penny stocks to buy ? At the top of my mind, there are a few things to look at. One of them is industry sentiment. Several industries ha...
Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma Resulting patent to extend Viracta's intellectual property protection into at least 20...